Menu

1 / 2

Sellas' experimental blood cancer immunotherapy reduced risk of death in clinical trial

Business - Latest - Google News·1 day ago
#zLEbT4hD
#world#news#statnews#adam#biotech
Reading 0:00
15s threshold

The unexpected result is good news for patients with acute myeloid leukemia

Histopathology from patient with acute myeloid leukemia. CDC

Nov. 17, 2026

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard , a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.